Chondroitin 6‐sulphate synthesis is up‐regulated in injured CNS, induced by injury‐related cytokines and enhanced in axon‐growth inhibitory glia

Publisher Website
Google Scholar
Abstract
Chondroitin sulphate proteoglycans (CSPGs) are up‐regulated in the CNS after injury and inhibit axon regeneration mainly through their glycosaminoglycan (CS‐GAG) chains. We have analysed the mRNA levels of the CS‐GAG synthesizing enzymes and measured the CS‐GAG disaccharide composition by chromatography and immunocytochemistry. Chondroitin 6‐sulfotransferase 1 (C6ST1) is up‐regulated in most glial types around cortical injuries, and its sulphated product CS‐C is also selectively up‐regulated. Treatment with TGFα and TGFβ, which are released after brain injury, promotes the expression of C6ST1 and the synthesis of 6‐sulphated CS‐GAGs in primary astrocytes. Oligodendrocytes, oligodendrocyte precursors and meningeal cells are all inhibitory to axon regeneration, and all express high levels of CS‐GAG, including high levels of 6‐sulphated GAG. In axon growth‐inhibitory Neu7 astrocytes C6ST1 and 6‐sulphated GAGs are expressed at high levels, whereas in permissive A7 astrocytes they are not detectable. These results suggest that the up‐regulation of CSPG after CNS injury is associated with a specific sulphation pattern on CS‐GAGs, mediating the inhibitory properties of proteoglycans on axonal regeneration.